X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 29,304 | 25,577 | 20,154 | 20,570 | 21,268 |
| Operating Income | -29,304 | -25,577 | -20,154 | -20,570 | -21,268 |
| Interest Expense | 1,109 | 1,144 | 1,018 | 918 | 913 |
| Other Income | 6,397 | -2,369 | -427 | 280 | 239 |
| Pre-tax Income | -24,016 | -29,090 | -21,599 | -21,208 | -21,942 |
| Income Tax | 4 | 14 | -13 | 4 | 23 |
| Net Income Continuous | -24,020 | -29,104 | -21,586 | -21,212 | -21,965 |
| Net Income | $-24,020 | $-29,104 | $-21,586 | $-21,212 | $-21,965 |
| EPS Basic Total Ops | -4.80 | 1.80 | -7.81 | -18.02 | -21.62 |
| EPS Basic Continuous Ops | -4.94 | 0.94 | -7.79 | -17.98 | -19.55 |
| EPS Diluted Total Ops | -4.80 | 1.80 | -7.81 | -18.02 | -21.62 |
| EPS Diluted Continuous Ops | -4.94 | 0.94 | -7.79 | -17.98 | -19.55 |
| EBITDA(a) | $-29,177 | $-25,453 | $-20,030 | $-20,438 | $-21,135 |